May 16, 2022 / 12:30PM GMT
Operator
Greetings, and welcome to Synthetic Biologics' First Quarter 2022 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Dean Schwartz of LifeSci Advisors. Please go ahead, sir.
Dean Schwartz -
Thank you, operator, and good morning, everyone. Welcome to Synthetic Biologics' 2022 First Quarter Investor Conference Call. Leading the call today will be Steven Shallcross, Chief Executive and Chief Financial Officer of Synthetic Biologics; Dr. Vince Wacher, Head of Corporate and Product Development of Synthetic Biologics; Dr. Manel Cascalló, General Director of Synthetic Biologics, European subsidiary; and Dr. Frank Tufaro, Chief Operating Officer, are also on the call and will be available to answer questions during the Q&A session.
Synthetic Biologics issued a press release this morning, which provided operational highlights and included the financial results for the first quarter ending March 31, 2022. The press release can be found in the
Q1 2022 Synthetic Biologics Inc Earnings Call Transcript
Feb 15, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers